Global Artificial Cardiopulmonary Machine Market Outlook 2022

SKU ID : QYR-19789065 | Publishing Date : 30-Dec-2021 | No. of pages : 108

Detailed TOC of Global Artificial Cardiopulmonary Machine Market Outlook 2022

1 Artificial Cardiopulmonary Machine Market Overview
    1.1 Product Overview and Scope of Artificial Cardiopulmonary Machine
    1.2 Artificial Cardiopulmonary Machine Segment by Type
        1.2.1 Global Artificial Cardiopulmonary Machine Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Single Roller Pump HLM
        1.2.3 Double Roller Pump HLM
    1.3 Artificial Cardiopulmonary Machine Segment by Application
        1.3.1 Global Artificial Cardiopulmonary Machine Sales Comparison by Application: (2021-2027)
        1.3.2 Cardiac Surgery
        1.3.3 Lung Transplant Operation
        1.3.4 Acute Respiratory Failure Treatment
        1.3.5 Others
    1.4 Global Artificial Cardiopulmonary Machine Market Size Estimates and Forecasts
        1.4.1 Global Artificial Cardiopulmonary Machine Revenue 2016-2027
        1.4.2 Global Artificial Cardiopulmonary Machine Sales 2016-2027
        1.4.3 Artificial Cardiopulmonary Machine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Cardiopulmonary Machine Market Competition by Manufacturers
    2.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Artificial Cardiopulmonary Machine Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Artificial Cardiopulmonary Machine Manufacturing Sites, Area Served, Product Type
    2.5 Artificial Cardiopulmonary Machine Market Competitive Situation and Trends
        2.5.1 Artificial Cardiopulmonary Machine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Artificial Cardiopulmonary Machine Players Market Share by Revenue
        2.5.3 Global Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Cardiopulmonary Machine Retrospective Market Scenario by Region
    3.1 Global Artificial Cardiopulmonary Machine Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Artificial Cardiopulmonary Machine Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
        3.3.1 North America Artificial Cardiopulmonary Machine Sales by Country
        3.3.2 North America Artificial Cardiopulmonary Machine Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Artificial Cardiopulmonary Machine Market Facts & Figures by Country
        3.4.1 Europe Artificial Cardiopulmonary Machine Sales by Country
        3.4.2 Europe Artificial Cardiopulmonary Machine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Artificial Cardiopulmonary Machine Market Facts & Figures by Region
        3.5.1 Asia Pacific Artificial Cardiopulmonary Machine Sales by Region
        3.5.2 Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Artificial Cardiopulmonary Machine Market Facts & Figures by Country
        3.6.1 Latin America Artificial Cardiopulmonary Machine Sales by Country
        3.6.2 Latin America Artificial Cardiopulmonary Machine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Artificial Cardiopulmonary Machine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country
        3.7.2 Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Artificial Cardiopulmonary Machine Historic Market Analysis by Type
    4.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2016-2021)
    4.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Type (2016-2021)
    4.3 Global Artificial Cardiopulmonary Machine Price by Type (2016-2021)

5 Global Artificial Cardiopulmonary Machine Historic Market Analysis by Application
    5.1 Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2016-2021)
    5.2 Global Artificial Cardiopulmonary Machine Revenue Market Share by Application (2016-2021)
    5.3 Global Artificial Cardiopulmonary Machine Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 LivaNova (Sorin)
        6.1.1 LivaNova (Sorin) Corporation Information
        6.1.2 LivaNova (Sorin) Description and Business Overview
        6.1.3 LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 LivaNova (Sorin) Artificial Cardiopulmonary Machine Product Portfolio
        6.1.5 LivaNova (Sorin) Recent Developments/Updates
    6.2 Getinge (Maquet)
        6.2.1 Getinge (Maquet) Corporation Information
        6.2.2 Getinge (Maquet) Description and Business Overview
        6.2.3 Getinge (Maquet) Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Getinge (Maquet) Artificial Cardiopulmonary Machine Product Portfolio
        6.2.5 Getinge (Maquet) Recent Developments/Updates
    6.3 Medtronic
        6.3.1 Medtronic Corporation Information
        6.3.2 Medtronic Description and Business Overview
        6.3.3 Medtronic Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Medtronic Artificial Cardiopulmonary Machine Product Portfolio
        6.3.5 Medtronic Recent Developments/Updates
    6.4 Terumo CV Group
        6.4.1 Terumo CV Group Corporation Information
        6.4.2 Terumo CV Group Description and Business Overview
        6.4.3 Terumo CV Group Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Terumo CV Group Artificial Cardiopulmonary Machine Product Portfolio
        6.4.5 Terumo CV Group Recent Developments/Updates
    6.5 Braile Biomedica
        6.5.1 Braile Biomedica Corporation Information
        6.5.2 Braile Biomedica Description and Business Overview
        6.5.3 Braile Biomedica Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Braile Biomedica Artificial Cardiopulmonary Machine Product Portfolio
        6.5.5 Braile Biomedica Recent Developments/Updates
    6.6 Tianjin Medical
        6.6.1 Tianjin Medical Corporation Information
        6.6.2 Tianjin Medical Description and Business Overview
        6.6.3 Tianjin Medical Artificial Cardiopulmonary Machine Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Tianjin Medical Artificial Cardiopulmonary Machine Product Portfolio
        6.6.5 Tianjin Medical Recent Developments/Updates

7 Artificial Cardiopulmonary Machine Manufacturing Cost Analysis
    7.1 Artificial Cardiopulmonary Machine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
    7.4 Artificial Cardiopulmonary Machine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Artificial Cardiopulmonary Machine Distributors List
    8.3 Artificial Cardiopulmonary Machine Customers

9 Artificial Cardiopulmonary Machine Market Dynamics
    9.1 Artificial Cardiopulmonary Machine Industry Trends
    9.2 Artificial Cardiopulmonary Machine Growth Drivers
    9.3 Artificial Cardiopulmonary Machine Market Challenges
    9.4 Artificial Cardiopulmonary Machine Market Restraints

10 Global Market Forecast
    10.1 Artificial Cardiopulmonary Machine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Artificial Cardiopulmonary Machine by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Type (2022-2027)
    10.2 Artificial Cardiopulmonary Machine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Artificial Cardiopulmonary Machine by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Application (2022-2027)
    10.3 Artificial Cardiopulmonary Machine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Artificial Cardiopulmonary Machine by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Artificial Cardiopulmonary Machine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Artificial Cardiopulmonary Machine Market Outlook 2022

List of Tables
    Table 1. Global Artificial Cardiopulmonary Machine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Artificial Cardiopulmonary Machine Sales (K Units) Comparison by Application (2021-2027)
    Table 3. Global Artificial Cardiopulmonary Machine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Artificial Cardiopulmonary Machine Covered in This Study
    Table 5. Global Artificial Cardiopulmonary Machine Sales (K Units) of Key Manufacturers (2016-2021)
    Table 6. Global Artificial Cardiopulmonary Machine Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Artificial Cardiopulmonary Machine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Artificial Cardiopulmonary Machine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Artificial Cardiopulmonary Machine Manufacturing Sites and Area Served
    Table 11. Manufacturers Artificial Cardiopulmonary Machine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Artificial Cardiopulmonary Machine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Cardiopulmonary Machine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Artificial Cardiopulmonary Machine Sales by Region (2016-2021) & (K Units)
    Table 16. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2016-2021)
    Table 17. Global Artificial Cardiopulmonary Machine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Artificial Cardiopulmonary Machine Sales by Country (2016-2021) & (K Units)
    Table 19. North America Artificial Cardiopulmonary Machine Sales Market Share by Country (2016-2021)
    Table 20. North America Artificial Cardiopulmonary Machine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Artificial Cardiopulmonary Machine Sales by Country (2016-2021) & (K Units)
    Table 23. Europe Artificial Cardiopulmonary Machine Sales Market Share by Country (2016-2021)
    Table 24. Europe Artificial Cardiopulmonary Machine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Artificial Cardiopulmonary Machine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Artificial Cardiopulmonary Machine Sales by Region (2016-2021) & (K Units)
    Table 27. Asia Pacific Artificial Cardiopulmonary Machine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Artificial Cardiopulmonary Machine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Artificial Cardiopulmonary Machine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Artificial Cardiopulmonary Machine Sales by Country (2016-2021) & (K Units)
    Table 31. Latin America Artificial Cardiopulmonary Machine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Artificial Cardiopulmonary Machine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Artificial Cardiopulmonary Machine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Artificial Cardiopulmonary Machine Sales by Country (2016-2021) & (K Units)
    Table 35. Middle East and Africa Artificial Cardiopulmonary Machine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Artificial Cardiopulmonary Machine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Artificial Cardiopulmonary Machine Revenue Market Share by Country (2016-2021)
    Table 38. Global Artificial Cardiopulmonary Machine Sales (K Units) by Type (2016-2021)
    Table 39. Global Artificial Cardiopulmonary Machine Sales Market Share by Type (2016-2021)
    Table 40. Global Artificial Cardiopulmonary Machine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Artificial Cardiopulmonary Machine Revenue Share by Type (2016-2021)
    Table 42. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Type (2016-2021)
    Table 43. Global Artificial Cardiopulmonary Machine Sales (K Units) by Application (2016-2021)
    Table 44. Global Artificial Cardiopulmonary Machine Sales Market Share by Application (2016-2021)
    Table 45. Global Artificial Cardiopulmonary Machine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Artificial Cardiopulmonary Machine Revenue Share by Application (2016-2021)
    Table 47. Global Artificial Cardiopulmonary Machine Price (US$/Unit) by Application (2016-2021)
    Table 48. LivaNova (Sorin) Corporation Information
    Table 49. LivaNova (Sorin) Description and Business Overview
    Table 50. LivaNova (Sorin) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 51. LivaNova (Sorin) Artificial Cardiopulmonary Machine Product
    Table 52. LivaNova (Sorin) Recent Developments/Updates
    Table 53. Getinge (Maquet) Corporation Information
    Table 54. Getinge (Maquet) Description and Business Overview
    Table 55. Getinge (Maquet) Artificial Cardiopulmonary Machine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 56. Getinge (Maquet) Artificial Cardiopulmonary Machine Product
    Table 57. Getinge (Maquet) Recent Developments/Updates
    Table 58. Medtronic Corporation Information
    Table 59. Medtronic Description and Business Overview
    Table 60. Medtronic Artificial Cardiopulmonary Machine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 61. Medtronic Artificial Cardiopulmonary Machine Product
    Table 62. Medtronic Recent Developments/Updates
    Table 63. Terumo CV Group Corporation Information
    Table 64. Terumo CV Group Description and Business Overview
    Table 65. Terumo CV Group Artificial Cardiopulmonary Machine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 66. Terumo CV Group Artificial Cardiopulmonary Machine Product
    Table 67. Terumo CV Group Recent Developments/Updates
    Table 68. Braile Biomedica Corporation Information
    Table 69. Braile Biomedica Description and Business Overview
    Table 70. Braile Biomedica Artificial Cardiopulmonary Machine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 71. Braile Biomedica Artificial Cardiopulmonary Machine Product
    Table 72. Braile Biomedica Recent Developments/Updates
    Table 73. Tianjin Medical Corporation Information
    Table 74. Tianjin Medical Description and Business Overview
    Table 75. Tianjin Medical Artificial Cardiopulmonary Machine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 76. Tianjin Medical Artificial Cardiopulmonary Machine Product
    Table 77. Tianjin Medical Recent Developments/Updates
    Table 78. Production Base and Market Concentration Rate of Raw Material
    Table 79. Key Suppliers of Raw Materials
    Table 80. Artificial Cardiopulmonary Machine Distributors List
    Table 81. Artificial Cardiopulmonary Machine Customers List
    Table 82. Artificial Cardiopulmonary Machine Market Trends
    Table 83. Artificial Cardiopulmonary Machine Growth Drivers
    Table 84. Artificial Cardiopulmonary Machine Market Challenges
    Table 85. Artificial Cardiopulmonary Machine Market Restraints
    Table 86. Global Artificial Cardiopulmonary Machine Sales Forecast by Type (2022-2027) & (K Units)
    Table 87. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Type (2022-2027)
    Table 88. Global Artificial Cardiopulmonary Machine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 89. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Type (2022-2027)
    Table 90. Global Artificial Cardiopulmonary Machine Sales Forecast by Application (2022-2027) & (K Units)
    Table 91. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Application (2022-2027)
    Table 92. Global Artificial Cardiopulmonary Machine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 93. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Application (2022-2027)
    Table 94. Global Artificial Cardiopulmonary Machine Sales Forecast by Region (2022-2027) & (K Units)
    Table 95. Global Artificial Cardiopulmonary Machine Sales Market Share Forecast by Region (2022-2027)
    Table 96. Global Artificial Cardiopulmonary Machine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 97. Global Artificial Cardiopulmonary Machine Revenue Market Share Forecast by Region (2022-2027)
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Artificial Cardiopulmonary Machine
    Figure 2. Global Artificial Cardiopulmonary Machine Market Share by Type in 2020 & 2027
    Figure 3. Single Roller Pump HLM Product Picture
    Figure 4. Double Roller Pump HLM Product Picture
    Figure 5. Global Artificial Cardiopulmonary Machine Market Share by Application in 2020 & 2027
    Figure 6. Cardiac Surgery
    Figure 7. Lung Transplant Operation
    Figure 8. Acute Respiratory Failure Treatment
    Figure 9. Others
    Figure 10. Global Artificial Cardiopulmonary Machine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Artificial Cardiopulmonary Machine Market Size 2016-2027 (US$ Million)
    Figure 12. Global Artificial Cardiopulmonary Machine Sales 2016-2027 (K Units)
    Figure 13. Global Artificial Cardiopulmonary Machine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Artificial Cardiopulmonary Machine Sales Share by Manufacturers in 2020
    Figure 15. Global Artificial Cardiopulmonary Machine Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Artificial Cardiopulmonary Machine Players: Market Share by Revenue in 2020
    Figure 17. Artificial Cardiopulmonary Machine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Artificial Cardiopulmonary Machine Sales Market Share by Region (2016-2021)
    Figure 19. Global Artificial Cardiopulmonary Machine Sales Market Share by Region in 2020
    Figure 20. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region (2016-2021)
    Figure 21. Global Artificial Cardiopulmonary Machine Revenue Market Share by Region in 2020
    Figure 22. United States Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. China Taiwan Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. UAE Artificial Cardiopulmonary Machine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Artificial Cardiopulmonary Machine by Type (2016-2021)
    Figure 45. Sales Market Share of Artificial Cardiopulmonary Machine by Application (2016-2021)
    Figure 46. Sales Market Share of Artificial Cardiopulmonary Machine by Application in 2020
    Figure 47. Revenue Share of Artificial Cardiopulmonary Machine by Application (2016-2021)
    Figure 48. Revenue Share of Artificial Cardiopulmonary Machine by Application in 2020
    Figure 49. Manufacturing Cost Structure of Artificial Cardiopulmonary Machine
    Figure 50. Manufacturing Process Analysis of Artificial Cardiopulmonary Machine
    Figure 51. Artificial Cardiopulmonary Machine Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed